Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. - Sorbonne Université Access content directly
Journal Articles Lung Cancer Year : 2009

Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.

Armelle Lavolé
  • Function : Author
Laurence Baudrin
  • Function : Author
Marie Wislez
  • Function : Author
Gilles Pialoux
  • Function : Author
Jacques Cadranel
  • Function : Author
  • PersonId : 901162

Abstract

OBJECTIVE: To evaluate the impact of highly active antiretroviral therapy (HAART) on survival in HIV infected patients with non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: All consecutive HIV infected patients with NSCLC diagnosed between 06/1996 and 03/2007 at two University hospitals in Paris (France) were prospectively followed until death. The association between survival and clinical and biological factors was analyzed by univariate and multivariate models. Survival analysis was performed by Kaplan-Meier estimates and the Cox proportional hazards regression model. RESULTS: During the study period, NSCLC was diagnosed in 49 consecutive HIV infected patients (median age 46 years); 84% had advanced disease. Median survival was 8.1 months (range 5-10 months). In multivariate analysis, baseline parameters with significant positive impact on survival included performance status (PS) < or =1 (HR=0.2, 95%CI [0.09, 0.46], p=0.0001), stage I-II disease (HR=0.15, 95%CI [0.04, 0.53], p=0.003), and use of HAART (HR=0.4, 95%CI [0.2, 0.9], p=0.027). CONCLUSION: HAART is a good prognostic factor for survival in HIV infected patients with NSCLC. Stage of disease and PS are two other valid survival prognostic factors.

Dates and versions

hal-00596986 , version 1 (30-05-2011)

Identifiers

Cite

Armelle Lavolé, Christos Chouaïd, Laurence Baudrin, Marie Wislez, Gilles Raguin, et al.. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.. Lung Cancer, 2009, 65 (3), pp.345-50. ⟨10.1016/j.lungcan.2008.11.018⟩. ⟨hal-00596986⟩
43 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More